Long-term results of patients undergoing
โ
Ivo W. Graziadei; Russell H. Wiesner; Paul J. Marotta; Michael K. Porayko; J. Ei
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 102 KB
๐ 2 views
Liver transplantation is the only effective therapeutic option for patients with end-stage liver disease due to primary sclerosing cholangitis (PSC). In this study, we analyzed a single center's experience with 150 consecutive PSC patients who received 174 liver allografts. Mean follow-up was 55 mon